Transcat, Inc. (NASDAQ:TRNS – Free Report) – Northland Capmk lowered their FY2025 earnings per share estimates for Transcat in a research report issued on Wednesday, January 29th. Northland Capmk analyst E. Jackson now expects that the scientific and technical instruments company will post earnings per share of $2.24 for the year, down from their prior estimate of $2.34. The consensus estimate for Transcat’s current full-year earnings is $2.39 per share. Northland Capmk also issued estimates for Transcat’s Q4 2025 earnings at $0.59 EPS and FY2026 earnings at $2.28 EPS.
Transcat (NASDAQ:TRNS – Get Free Report) last released its quarterly earnings data on Monday, January 27th. The scientific and technical instruments company reported $0.45 earnings per share for the quarter, topping analysts’ consensus estimates of $0.38 by $0.07. Transcat had a net margin of 6.22% and a return on equity of 7.43%. During the same period in the previous year, the firm posted $0.56 EPS.
Read Our Latest Research Report on TRNS
Transcat Trading Up 0.4 %
Shares of NASDAQ:TRNS opened at $77.02 on Thursday. The firm’s 50 day moving average is $103.15 and its two-hundred day moving average is $114.18. The firm has a market capitalization of $708.58 million, a P/E ratio of 41.63 and a beta of 0.71. Transcat has a 52 week low of $73.37 and a 52 week high of $147.12.
Institutional Trading of Transcat
Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Conestoga Capital Advisors LLC grew its position in Transcat by 17.9% in the third quarter. Conestoga Capital Advisors LLC now owns 907,191 shares of the scientific and technical instruments company’s stock worth $109,561,000 after buying an additional 137,830 shares during the last quarter. Millrace Asset Group Inc. bought a new stake in shares of Transcat during the 3rd quarter worth $655,000. State Street Corp grew its holdings in shares of Transcat by 8.1% in the 3rd quarter. State Street Corp now owns 207,230 shares of the scientific and technical instruments company’s stock worth $25,027,000 after acquiring an additional 15,514 shares during the last quarter. Champlain Investment Partners LLC raised its position in shares of Transcat by 22.1% during the third quarter. Champlain Investment Partners LLC now owns 409,500 shares of the scientific and technical instruments company’s stock worth $49,455,000 after purchasing an additional 74,169 shares during the period. Finally, Geode Capital Management LLC lifted its holdings in shares of Transcat by 5.4% during the third quarter. Geode Capital Management LLC now owns 217,473 shares of the scientific and technical instruments company’s stock valued at $26,269,000 after purchasing an additional 11,106 shares during the last quarter. 98.34% of the stock is owned by institutional investors and hedge funds.
About Transcat
Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.
Featured Stories
- Five stocks we like better than Transcat
- The 3 Best Blue-Chip Stocks to Buy Now
- Nebius Group: Market Overreaction or Real AI Disruption?
- How to Choose Top Rated Stocks
- The Best Way to Invest in Gold Is…
- How to Invest in Insurance Companies: A Guide
- Why Nike Stock Could Be 2025’s Top Comeback Play
Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.